OSCR

Oscar Health Inc
NYSEHEALTHCAREHEALTHCARE PLANS

Key Statistics

Market Cap
$9.74B
P/E Ratio
25.24
EPS
$1.25
Beta
2.38
52W High
$33.27
52W Low
$10.69
50-Day MA
$29.42
200-Day MA
$19.39
Dividend Yield
Profit Margin
3.60%
Forward P/E
588.24
PEG Ratio

About Oscar Health Inc

Oscar Health, Inc. offers health insurance products and services to individuals, families, and businesses in the United States. The company is headquartered in New York, New York.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$15.32B
Gross Profit (TTM)$3.09B
EBITDA$657.96M
Operating Margin7.96%
Return on Equity34.30%
Return on Assets4.47%
Revenue/Share (TTM)$53.60
Book Value$6.66
Price-to-Book4.93
Price-to-Sales (TTM)0.64
EV/Revenue0.422
EV/EBITDA
Quarterly Earnings Growth (YoY)125.60%
Quarterly Revenue Growth (YoY)70.40%
Shares Outstanding$273.47M
Float$263.10M
% Insiders5.24%
% Institutions73.77%

Historical Volatility

HV 10-Day
89.82%
HV 20-Day
77.22%
HV 30-Day
66.88%
HV 60-Day
71.76%
HV Rank
54.0%

Volatility is currently expanding

Analyst Ratings

Consensus ($30.40 target)
3
Strong Buy
7
Hold
1
Strong Sell

Latest News

GoodRx and Oscar Health Tout Tech as Consumer Needs Change

The latest earnings from Oscar Health and GoodRx show both companies dealing with a changing customer base. The former company reported half-year earnings Thursday (Aug. 6) showing record profitability for the first six months of 2026, with revenues surging 70% to $4.9 billion.

PYMNTS8/6/2026Positive
Oscar Health (OSCR) Reports Q2 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Oscar Health (OSCR) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks Investment Research8/6/2026Positive
Oscar Health, Inc. (OSCR) Q2 Earnings Beat Estimates

Oscar Health, Inc. (OSCR) came out with quarterly earnings of $1.1 per share, beating the Zacks Consensus Estimate of $0.43 per share. This compares to a loss of $0.89 per share a year ago.

Zacks Investment Research8/6/2026Positive

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on OSCR and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 8/18/2026